SHL Telemedicine Ltd. (VTX:SHLTN) insiders who acquired shares over the previous 12 months, can probably afford to ignore the recent 14% decline in the stock price. Reason being, despite the recent loss, insiders original purchase value of US$1.14m is now worth US$1.70m.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
The Non-Executive Director Ido Neuberger made the biggest insider purchase in the last 12 months. That single transaction was for CHF686k worth of shares at a price of CHF0.61 each. Even though the purchase was made at a significantly lower price than the recent price (CHF0.92), we still think insider buying is a positive. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.
SHL Telemedicine insiders may have bought shares in the last year, but they didn't sell any. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
See our latest analysis for SHL Telemedicine
There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 37% of SHL Telemedicine shares, worth about CHF12m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
It doesn't really mean much that no insider has traded SHL Telemedicine shares in the last quarter. However, our analysis of transactions over the last year is heartening. Insiders own shares in SHL Telemedicine and we see no evidence to suggest they are worried about the future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Be aware that SHL Telemedicine is showing 4 warning signs in our investment analysis, and 3 of those can't be ignored...
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.